诺辉健康(06606.HK)根据香港医疗仪器行政管理制度登记三款产品

阿斯达克财经11-19

诺辉健康(06606.HK) 公布，近期推出了三款产品，即常卫清，为一种专有非侵入性粪便FIT-DNA结直肠癌筛查测试产品；噗噗管，一种专有非侵入性粪便FIT筛查产品，用来测试与结直肠癌相关的血红蛋白生物标志物；及幽幽管，一种基于粪便样本幽门螺杆菌的筛查消费者自测产品。产品已根据医疗仪器行政管理制度(MDACS)于香港卫生署成功登记。MDACS为医疗仪器登记制度，据此，医疗仪器制造商及进口商在证明...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2484918507?lang=zh_CN&edition=full","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220113123125356_s.jpg","is_english":false,"pubTime":"2024-11-19 17:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2484918507","market":"fut","top_or_hot":-1,"title":"诺辉健康(06606.HK)根据香港医疗仪器行政管理制度登记三款产品","media":"阿斯达克财经","content":"<div>\n<p>诺辉健康(06606.HK) 公布，近期推出了三款产品，即常卫清，为一种专有非侵入性粪便FIT-DNA结直肠癌筛查测试产品；噗噗管，一种专有非侵入性粪便FIT筛查产品，用来测试与结直肠癌相关的血红蛋白生物标志物；及幽幽管，一种基于粪便样本幽门螺杆菌的筛查消费者自测产品。产品已根据医疗仪器行政管理制度(MDACS)于香港卫生署成功登记。MDACS为医疗仪器登记制度，据此，医疗仪器制造商及进口商在证明...</p>\n\n<a href=\"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1397881/latest-news/AAFN\">网页链接</a>\n\n</div>\n","source":"aastocks_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>诺辉健康(06606.HK)根据香港医疗仪器行政管理制度登记三款产品</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n诺辉健康(06606.HK)根据香港医疗仪器行政管理制度登记三款产品\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-19 17:35 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1397881/latest-news/AAFN><strong>阿斯达克财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>诺辉健康(06606.HK) 公布，近期推出了三款产品，即常卫清，为一种专有非侵入性粪便FIT-DNA结直肠癌筛查测试产品；噗噗管，一种专有非侵入性粪便FIT筛查产品，用来测试与结直肠癌相关的血红蛋白生物标志物；及幽幽管，一种基于粪便样本幽门螺杆菌的筛查消费者自测产品。产品已根据医疗仪器行政管理制度(MDACS)于香港卫生署成功登记。MDACS为医疗仪器登记制度，据此，医疗仪器制造商及进口商在证明...</p>\n\n<a href=\"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1397881/latest-news/AAFN\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1574","symbol_name":"生物医药B类股","start_time":0,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1397881/latest-news/AAFN","article_id":"2484918507","we_media_id":null,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220113123125356_s.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2484918507","pubTimestamp":1732008900,"columns":[],"sourceInfo":{"source_id":"aastocks_highlight","name":"阿思達克財經"},"weMediaInfo":null,"summary":"产品已根据医疗仪器行政管理制度于香港卫生署成功登记。MDACS为医疗仪器登记制度，据此，医疗仪器制造商及进口商在证明有关医疗仪器符合公认的安全及性能标准后，可自愿向卫生署登记其医疗仪器。公司股份已自3月28日起于联交所暂停买卖，并将继续暂停买卖直至履行复牌指引。(港股报价延迟最少十五分钟。","collect":0,"end_time":0,"defaultTopTitle":"aastocks.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159891":"医疗","BK1574":"生物医药B类股","06606":"诺辉健康","BK1219":"保健护理服务"},"translate_title":"Nuohui Health (06606. HK) registers three products under the Hong Kong Medical Device Administration System","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159891":1,"06606":1},"content_text":"诺辉健康(06606.HK) 公布，近期推出了三款产品，即常卫清，为一种专有非侵入性粪便FIT-DNA结直肠癌筛查测试产品；噗噗管，一种专有非侵入性粪便FIT筛查产品，用来测试与结直肠癌相关的血红蛋白生物标志物；及幽幽管，一种基于粪便样本幽门螺杆菌的筛查消费者自测产品。产品已根据医疗仪器行政管理制度(MDACS)于香港卫生署成功登记。MDACS为医疗仪器登记制度，据此，医疗仪器制造商及进口商在证明有关医疗仪器符合公认的安全及性能标准后，可自愿向卫生署登记其医疗仪器。公司股份已自3月28日起于联交所暂停买卖，并将继续暂停买卖直至履行复牌指引。(sl/u)(港股报价延迟最少十五分钟。)AASTOCKS新闻","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2484918507"}